Keywords: CMR, cardiac magnetic resonance; ICI, immune checkpoint inhibitor; IRAE, immune-related adverse event; IV, intravenous; IVIG, intravenous immunoglobulin; LGE, late gadolinium enhancement; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro–B-type natriuretic peptide; TTE, transthoracic echocardiogram; T cell; VA-ECMO, venoarterial extracorporeal membrane oxygenation; abatacept; cardiac arrest; cardiogenic shock; cervical cancer; extracorporeal membrane oxygenation; fulminant; heart failure; hsTnI, high-sensitivity troponin I; immune; immune checkpoint inhibitor; immunosuppressive; inflammation; inflammatory; myocarditis; troponin.